ctrl K

Watchlist Price Alert

Fusion Pharmaceuticals In... (FUSN)

NASDAQ: FUSN · Real-Time Price · USD

21.55

0.03 (0.14%)

At close: Jun 03, 2024, 8:00 PM

Fusion Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	61.92M	43.86M	52.9M	90.52M	65.34M	28.77M
Short-Term Investments	172.15M	127.01M	147.9M	131.88M	n/a	n/a
Long-Term Investments	14.58M	15.76M	19.99M	77.08M	1.5M	n/a
Other Long-Term Assets	849K	9.18M	9.42M	2.81M	1.5M	32K
Receivables	4.21M	1.72M	357K	794K	428K	483K
Inventory	n/a	-9.87M	10.38M	4.24M	503K	835K
Other Current Assets	5.1M	509K	233K	727K	278K	150K
Total Current Assets	243.4M	179M	211.76M	228.16M	66.55M	30.24M
Property-Plant & Equipment	23.9M	10.31M	9.45M	1.97M	1.27M	1.1M
Goodwill & Intangibles	-849K	n/a	n/a	n/a	-1.5M	n/a
Total Long-Term Assets	42.44M	40.07M	40.51M	82.51M	2.85M	1.16M
Total Assets	285.84M	219.06M	252.27M	310.68M	69.4M	31.39M
Account Payables	1.86M	2.69M	2.19M	3.4M	830K	349K
Deferred Revenue	333K	924K	1.54M	1M	n/a	n/a
Short-Term Debt	4.16M	1.44M	1.22M	n/a	n/a	n/a
Other Current Liabilities	9.86M	10.01M	7.56M	7.46M	3.44M	1.25M
Total Current Liabilities	16.22M	15.07M	12.51M	11.86M	4.27M	1.6M
Long-Term Debt	34.77M	38.81M	5.51M	n/a	5.74M	n/a
Other Long-Term Liabilities	301K	299K	297K	306K	92.87M	47.71M
Total Long-Term Liabilities	47.14M	41.78M	8.3M	4.31M	98.61M	47.71M
Total Liabilities	63.36M	56.84M	20.82M	16.16M	102.89M	49.31M
Total Debt	50.33M	40.25M	6.72M	n/a	5.74M	n/a
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-376.76M	-281.86M	-194.25M	-113.2M	-34.77M	-18.59M
Comprehensive Income	237K	-469K	-115K	44K	n/a	-138K
Shareholders Equity	222.48M	162.22M	231.46M	294.51M	-33.49M	-17.92M
Total Investments	186.74M	142.77M	167.88M	208.96M	1.5M	n/a